Proceedings of the International scientific and practical conference ―New York Global Science Conference 2026‖ (March 6-8, 2026) / Publisher website: www.naukainfo.com. – New York, USA, 2026. - 250 p.

204 steatosis and expression of fatty acid synthase in diet-induced nonalcoholic fatty liver disease in mice. J. Lipid Res. 2019;60:1311–1322. doi: 10.1194/jlr.M093799. 8. Zhou B., Jia L., Zhang Z., Xiang L., Yuan Y., Zheng P., Liu B., Ren X., Bian H., Xie L., et al. The Nuclear Orphan Receptor NR2F6 Promotes Hepatic Steatosis through Upregulation of Fatty Acid Transporter CD36. Adv. Sci. 2020;7:2002273. doi: 10.1002/advs.202002273. 9. Becares N., Gage M.C., Voisin M., Shrestha E., Martin-Gutierrez L., Liang N., Louie R., Pourcet B., Pello O.M., Luong T.V., et al. Impaired LXRα Phosphorylation Attenuates Progression of Fatty Liver Disease. Cell Rep. 2019;26:984–995.e6. doi: 10.1016/j.celrep.2018.12.094. 10. Kim MY, Bae JS, Kim TH, Park JM, Ahn YH. Role of transcription factor modifications in the pathogenesis of insulin resistance. Exp Diabetes Res. 2012;2012:716425. doi: 10.1155/2012/716425.